Evidence map›Paper›PMID 40903741›Full record

Trial reportBMC health services research2025

Barriers and facilitators to using practice facilitators to implement a remote cancer symptom management intervention: a mixed methods study.

Sarah A Minteer, Jennifer L Ridgeway, Deirdre R Pachman, Jessica D Austin, Joan M Griffin, Kathryn J Ruddy, Andrea L Cheville

Registry-linked trialAbstract readClinical Trial, Phase IMulticenter StudyPragmatic Clinical Trial
In one paragraph

Trial report in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03892967 (Enhanced, EHR-Facilitated Cancer Symptom Control), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03892967 nacompletednot on this map

Enhanced, EHR-Facilitated Cancer Symptom Control (E2C2) Trial

TypeinterventionalSponsorMayo ClinicRan2019 to 2023Enrolled50,207ConditionsHematopoietic and Lymphoid Cell Neoplasm, Malignant Solid NeoplasmArmsInterview, Quality-of-Life Assessment, Questionnaire Administration
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah A MinteerDepartment of Physical Medicine and Rehabilitation Research, Mayo Clinic, 200 First St SW, Rochester, MN, 55901, USA. minteer.sarah@mayo.edu.
Jennifer L RidgewayRobert D. and Patria E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Deirdre R PachmanDivision of Community Internal Medicine, Geriatrics, and Palliative Care, Mayo Clinic, Rochester, MN, USA.
Jessica D AustinDivsion of Epidemiology, Mayo Clinic, Phoenix, AZ, USA.
Joan M GriffinRobert D. and Patria E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
Kathryn J RuddyDepartment of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Andrea L ChevilleDepartment of Medical Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA.

Funding

Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical TrialUM1CA233033 · NCI · MAYO CLINIC ROCHESTER · PI CHEVILLE, ANDREA LYNNE · 2018 to 2018
$8.7M
National Cancer Institute of the National Institutes of Health UM1CA233033NCI NIH HHS UM1 CA233033
6 · The paper itself

Abstract

backgroundAs part of a pragmatic cluster-randomized trial for patients with cancer, we recruited representatives from each care setting and trained them to be practice facilitators ("Symptom Sages"). This mixed methods study evaluated barriers and facilitators individuals encountered in this role.

methodsSymptom Sages were invited to complete a brief web-based survey and semi-structured interview, developed using constructs from the Consolidated Framework for Implementation Research (CFIR) 2.0. Survey responses were summarized descriptively. Two researchers coded interview transcripts to CFIR 2.0 constructs, reviewed coded text, and created memos to identify themes. Final themes were agreed on via discussion.

resultsBetween August and November 2023, 12 practice facilitators participated (11 completed surveys and 7 completed interviews). Interviews revealed the following themes: 1) training and knowledge acquisition for the facilitator role were sufficient but time was not, 2) mixed perceptions of the intervention and inability to modify the intervention impacted role motivation, and 3) there were challenges motivating colleagues and getting organizational support. Survey results revealed similar findings.

conclusionTraining alone is insufficient for practice facilitators' success in the absence of allocated protected time. Additional implementation strategies may be needed to support adoption in oncology settings.

trial registrationThis trial was registered at ClinicalTrials.gov, NCT03892967, on March 25, 2019, https://clinicaltrials.gov/study/NCT03892967 .

Indexed as

NeoplasmsFemaleHumansInterviews as TopicMaleMiddle AgedSurveys and QuestionnairesTelemedicineCancerClinical championsElectronic patient reported outcome measuresImplementationPractice facilitators

Identifiers

PMID40903741
PMCPMC12409932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.